News of the WeekClinical Trials

Panel Proposes Rules for Research Abroad

See allHide authors and affiliations

Science  06 Oct 2000:
Vol. 290, Issue 5489, pp. 28
DOI: 10.1126/science.290.5489.28a

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Before scientists begin a clinical study in the developing world, they should make sure any successful treatment that results will be made available not just to trial participants but to the whole host country, according to a controversial recommendation from a presidential panel. The U.S. National Bioethics Advisory Commission (NBAC) on 29 September released draft guidelines that would set this high bar for clinical research in foreign countries. NBAC took up the issue last year in response to controversies over placebo-controlled trials involving HIV-infected mothers and international trials of AIDS vaccines.